Constitutive Notch2 signaling induces hepatic tumors in mice

Authors

  • Michael T. Dill,

    1. Department of Biomedicine, Hepatology Laboratory, University of Basel, Basel, Switzerland
    2. Division of Gastroenterology and Hepatology, University Hospital Basel, Basel, Switzerland
    Search for more papers by this author
  • Luigi Tornillo,

    1. Institute for Pathology, University Hospital Basel, Basel, Switzerland
    Search for more papers by this author
  • Thorsten Fritzius,

    1. Department of Biomedicine, Institute of Physiology, University of Basel, Basel, Switzerland
    Search for more papers by this author
  • Luigi Terracciano,

    1. Institute for Pathology, University Hospital Basel, Basel, Switzerland
    Search for more papers by this author
  • David Semela,

    1. Department of Biomedicine, Hepatology Laboratory, University of Basel, Basel, Switzerland
    2. Divison of Gastroenterology and Hepatology, Cantonal Hospital St. Gallen, St. Gallen, Switzerland
    Search for more papers by this author
  • Bernhard Bettler,

    Corresponding author
    1. Department of Biomedicine, Institute of Physiology, University of Basel, Basel, Switzerland
    • Bernhard Bettler, University of Basel, Department of Biomedicine, Institute of Physiology, Pharmazentrum, Klingelbergstrasse 50/70, CH-4056 Basel, Switzerland===

      Markus H. Heim, University of Basel, Department of Biomedicine, Hepatology Laboratory, Hebelstrasse 20, CH-4031 Basel, Switzerland===

      Jan S. Tchorz, University of Basel, Department of Biomedicine, Institute of Physiology, Pharmazentrum, Klingelbergstrasse 50/70, CH-4056 Basel, Switzerland===

    Search for more papers by this author
    • fax: (41)-61-2671628

  • Markus H. Heim,

    Corresponding author
    1. Department of Biomedicine, Hepatology Laboratory, University of Basel, Basel, Switzerland
    2. Division of Gastroenterology and Hepatology, University Hospital Basel, Basel, Switzerland
    • Bernhard Bettler, University of Basel, Department of Biomedicine, Institute of Physiology, Pharmazentrum, Klingelbergstrasse 50/70, CH-4056 Basel, Switzerland===

      Markus H. Heim, University of Basel, Department of Biomedicine, Hepatology Laboratory, Hebelstrasse 20, CH-4031 Basel, Switzerland===

      Jan S. Tchorz, University of Basel, Department of Biomedicine, Institute of Physiology, Pharmazentrum, Klingelbergstrasse 50/70, CH-4056 Basel, Switzerland===

    Search for more papers by this author
    • fax: (41)-61-2655352

  • Jan S. Tchorz

    Corresponding author
    1. Department of Biomedicine, Institute of Physiology, University of Basel, Basel, Switzerland
    • Bernhard Bettler, University of Basel, Department of Biomedicine, Institute of Physiology, Pharmazentrum, Klingelbergstrasse 50/70, CH-4056 Basel, Switzerland===

      Markus H. Heim, University of Basel, Department of Biomedicine, Hepatology Laboratory, Hebelstrasse 20, CH-4031 Basel, Switzerland===

      Jan S. Tchorz, University of Basel, Department of Biomedicine, Institute of Physiology, Pharmazentrum, Klingelbergstrasse 50/70, CH-4056 Basel, Switzerland===

    Search for more papers by this author
    • fax: (41)-61-2671628


  • Potential conflict of interest: Nothing to report.

  • Supported by Oncosuisse (KFP OCS-01613-12-2004) and Krebsliga Schweiz (KLS-02522-02-2010).

Abstract

Hepatocellular carcinoma (HCC) and cholangiocarcinoma (CCC) are the most common liver tumors and a leading cause for cancer-related death in men. Notch2 regulates cellular differentiation in the developing and adult liver. Although aberrant Notch signaling is implicated in various cancers, it is still unclear whether Notch2 regulates proliferation and differentiation in liver carcinogenesis and thereby contributes to HCC and CCC formation. Here, we investigated the oncogenic potential of constitutive Notch2 signaling in the liver. We show that liver-specific expression of the intracellular domain of Notch2 (N2ICD) in mice is sufficient to induce HCC formation and biliary hyperplasia. Specifically, constitutive N2ICD signaling in the liver leads to up-regulation of pro-proliferative genes and proliferation of hepatocytes and biliary epithelial cells (BECs). Using the diethylnitrosamine (DEN) HCC carcinogenesis model, we further show that constitutive Notch2 signaling accelerates DEN-induced HCC formation. DEN-induced HCCs with constitutive Notch2 signaling (DENN2ICD HCCs) exhibit a marked increase in size, proliferation, and expression of pro-proliferative genes when compared with HCCs from DEN-induced control mice (DENctrl HCCs). Moreover, DENN2ICD HCCs exhibit increased Sox9 messenger RNA (mRNA) levels and reduced Albumin and Alpha-fetoprotein mRNA levels, indicating that they are less differentiated than DENctrl HCCs. Additionally, DENN2ICD mice develop large hepatic cysts, dysplasia of the biliary epithelium, and eventually CCC. CCC formation in patients and DENN2ICD mice is accompanied by re-expression of hepatocyte nuclear factor 4α(HNF4α), possibly indicating dedifferentiation of BECs. Conclusion: Our data establish an oncogenic role for constitutive Notch2 signaling in liver cancer development. (HEPATOLOGY 2013)

Ancillary